MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

Funds managed by Blue Owl Capital, the New York-based alternative asset manager, has made a $2.5 billion investment in Point, a leading home equity investment (HEI) platform, to help the latter expand ...

Point and Blue Owl Capital have completed a $390 million securitization of home equity investment assets, marking the largest bond issuance in the history of the HEI space. This transaction reflects ...

HEICO Corporation (NYSE:HEI) is among the 12 Best Defense Stocks to Buy Right Now. The company manufactures jet engines and aircraft parts. It also supports the government through activities such as ...

Summit founder and president Quint Rubald, CEO Jeff Evrard and the broader management team will remain shareholders and continue to lead the company Founded in 1999, Summit has locations across 37 ...

Pharmaceutical giant MSD is slashing $3bn (€2.59bn) from its annual spending as part of global job cut but said it will not be closing any of its Irish sites. Pharmaceutical giant MSD is slashing $3bn ...

Aerospace and defense company HEICO (NSYE:HEI) will be reporting earnings tomorrow after the bell. Here’s what to expect. HEICO beat analysts’ revenue expectations by 5.4% last quarter, reporting ...

Home Equity Investment (HEI) is a relatively new option for private equity real estate investors, and one that carries significant promise. Essentially, is a secured contract where a homeowner ...

BDT & MSD Partners alum Adam Piekarski is starting anew and has formed Derby Lane Partners, a new real estate credit investment firm, according to a person with knowledge of the matter. New York-based ...

MSD's Gardasil®9, a nine-valent HPV vaccine, is approved for use in males between 16 and 26 years old by China's National Medical Products Administration on Monday. [Photo provided to ...

Hyderabad: US pharma giant Merck & Co Inc, which does business as Merck Sharp & Dohme (MSD) outside the United States and Canada, opened its first technology centre in India at Hyderabad this week, ...